240 related articles for article (PubMed ID: 9464825)
1. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity.
Fisch P; Meuer E; Pende D; Rothenfusser S; Viale O; Kock S; Ferrone S; Fradelizi D; Klein G; Moretta L; Rammensee HG; Boon T; Coulie P; van der Bruggen P
Eur J Immunol; 1997 Dec; 27(12):3368-79. PubMed ID: 9464825
[TBL] [Abstract][Full Text] [Related]
2. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
Bakker AB; Phillips JH; Figdor CG; Lanier LL
J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
[TBL] [Abstract][Full Text] [Related]
3. Human Vgamma9/Vdelta2 effector memory T cells express the killer cell lectin-like receptor G1 (KLRG1).
Eberl M; Engel R; Aberle S; Fisch P; Jomaa H; Pircher H
J Leukoc Biol; 2005 Jan; 77(1):67-70. PubMed ID: 15498816
[TBL] [Abstract][Full Text] [Related]
4. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors.
Halary F; Peyrat MA; Champagne E; Lopez-Botet M; Moretta A; Moretta L; Vié H; Fournié JJ; Bonneville M
Eur J Immunol; 1997 Nov; 27(11):2812-21. PubMed ID: 9394804
[TBL] [Abstract][Full Text] [Related]
5. Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gammadelta T lymphocytes.
Rothenfusser S; Buchwald A; Kock S; Ferrone S; Fisch P
Cell Immunol; 2002 Jan; 215(1):32-44. PubMed ID: 12142034
[TBL] [Abstract][Full Text] [Related]
6. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
[TBL] [Abstract][Full Text] [Related]
7. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
[TBL] [Abstract][Full Text] [Related]
8. MHC-unrestricted cytotoxic and proliferative responses of two distinct human gamma/delta T cell subsets to Daudi cells.
Fisch P; Oettel K; Fudim N; Surfus JE; Malkovsky M; Sondel PM
J Immunol; 1992 Apr; 148(8):2315-23. PubMed ID: 1532810
[TBL] [Abstract][Full Text] [Related]
9. gammadelta-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-gamma response to Plasmodium falciparum malaria.
D'Ombrain MC; Hansen DS; Simpson KM; Schofield L
Eur J Immunol; 2007 Jul; 37(7):1864-73. PubMed ID: 17557374
[TBL] [Abstract][Full Text] [Related]
10. Acquisition of a stimulatory activity for Vgamma9/Vdelta2 T cells by a Burkitt's lymphoma cell line without loss of HLA class I expression.
L'Faqihi FE; Guiraud M; Dastugue N; Brousset P; Le Bouteiller P; Halary F; Bonneville M; Fournié JJ; Champagne E
Hum Immunol; 1999 Oct; 60(10):928-38. PubMed ID: 10566592
[TBL] [Abstract][Full Text] [Related]
11. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
[TBL] [Abstract][Full Text] [Related]
12. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
[TBL] [Abstract][Full Text] [Related]
13. Distinct gene expression in human Vdelta1 and Vdelta2 gammadelta T cells following non-TCR agonist stimulation.
Kress E; Hedges JF; Jutila MA
Mol Immunol; 2006 May; 43(12):2002-11. PubMed ID: 16423401
[TBL] [Abstract][Full Text] [Related]
14. Human V gamma 9-V delta 2 T cell receptor-gamma delta lymphocytes show specificity to Daudi Burkitt's lymphoma cells.
Sturm E; Braakman E; Fisch P; Vreugdenhil RJ; Sondel P; Bolhuis RL
J Immunol; 1990 Nov; 145(10):3202-8. PubMed ID: 2146317
[TBL] [Abstract][Full Text] [Related]
15. Regulation of gammadelta T cell survival by soluble HLA-I: involvement of CD8 and activating killer Ig-like receptors.
Poggi A; Contini P; Catellani S; Setti M; Murdaca G; Zocchi MR
Eur J Immunol; 2005 Sep; 35(9):2670-8. PubMed ID: 16114098
[TBL] [Abstract][Full Text] [Related]
16. Human peripheral gamma delta T cells are stimulated by Daudi Burkitt's lymphoma and not by any other Burkitt's lymphoma tested.
Kaur I; de Jong J; Schell K; Hank J; Fisch P; Sondel PM
Cell Immunol; 1994 Jun; 156(1):54-61. PubMed ID: 8200042
[TBL] [Abstract][Full Text] [Related]
17. Requirement for CD4+ T cells in the gammadelta T cell proliferative response to Daudi Burkitt's lymphoma.
Burns J; Lobo S; Bartholomew B
Cell Immunol; 1996 Nov; 174(1):19-24. PubMed ID: 8929450
[TBL] [Abstract][Full Text] [Related]
18. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
19. Activation of V gamma 9V delta 2 T cells by NKG2D.
Rincon-Orozco B; Kunzmann V; Wrobel P; Kabelitz D; Steinle A; Herrmann T
J Immunol; 2005 Aug; 175(4):2144-51. PubMed ID: 16081780
[TBL] [Abstract][Full Text] [Related]
20. Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.
Oyoshi MK; Nagata H; Kimura N; Zhang Y; Demachi A; Hara T; Kanegane H; Matsuo Y; Yamaguchi T; Morio T; Hirano A; Shimizu N; Yamamoto K
Am J Pathol; 2003 May; 162(5):1629-38. PubMed ID: 12707047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]